This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 May;21(5):1135-7.

doi: 10.1093/annonc/mdq044. Epub 2010 Mar 9.

Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa

A Italiano, C Delcambre, I Hostein, A L Cazeau, M Marty, A Avril, J-M Coindre, B Bui

PMID: 20215136
DOI: 10.1093/annonc/mdq044

Free article

Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa

A Italiano et al. Ann Oncol. 2010 May.

Free article

. 2010 May;21(5):1135-7.

doi: 10.1093/annonc/mdq044. Epub 2010 Mar 9.

Authors

A Italiano, C Delcambre, I Hostein, A L Cazeau, M Marty, A Avril, J-M Coindre, B Bui

PMID: 20215136
DOI: 10.1093/annonc/mdq044

No abstract available

PubMed Disclaimer

Similar articles

Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.
Wagner AJ, Malinowska-Kolodziej I, Morgan JA, Qin W, Fletcher CD, Vena N, Ligon AH, Antonescu CR, Ramaiya NH, Demetri GD, Kwiatkowski DJ, Maki RG. Wagner AJ, et al. J Clin Oncol. 2010 Feb 10;28(5):835-40. doi: 10.1200/JCO.2009.25.2981. Epub 2010 Jan 4. J Clin Oncol. 2010. PMID: 20048174 Free PMC article.
Combination targeted therapy of VEGFR inhibitor, sorafenib, with an mTOR inhibitor, sirolimus induced a remakable response of rapid progressive Uterine PEComa.
Gao F, Huang C, Zhang Y, Sun R, Zhang Y, Wang H, Zhang S. Gao F, et al. Cancer Biol Ther. 2016 Jun 2;17(6):595-8. doi: 10.1080/15384047.2016.1167290. Epub 2016 Mar 30. Cancer Biol Ther. 2016. PMID: 27030639 Free PMC article.
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature.
Starbuck KD, Drake RD, Budd GT, Rose PG. Starbuck KD, et al. Anticancer Res. 2016 Nov;36(11):6161-6164. doi: 10.21873/anticanres.11208. Anticancer Res. 2016. PMID: 27793946 Review.
[mTOR and non-small cell lung cancer].
Wang L, Xu S, Yue W. Wang L, et al. Zhongguo Fei Ai Za Zhi. 2010 Jan;13(1):69-72. doi: 10.3779/j.issn.1009-3419.2010.01.13. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20672708 Free PMC article. Review. Chinese. No abstract available.
A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report.
Meredith L, Chao T, Nevler A, Basu Mallick A, Singla RK, McCue PA, Bowne WB, Jiang W. Meredith L, et al. Diagn Pathol. 2023 Apr 11;18(1):45. doi: 10.1186/s13000-023-01323-x. Diagn Pathol. 2023. PMID: 37041531 Free PMC article.

See all similar articles

Cited by

PEComa-A Rare Liver Tumor.
Krawczyk M, Ziarkiewicz-Wróblewska B, Wróblewski T, Podgórska J, Grzybowski J, Gierej B, Krawczyk P, Nyckowski P, Kornasiewicz O, Patkowski W, Remiszewski P, Zając K, Grąt M. Krawczyk M, et al. J Clin Med. 2021 Apr 18;10(8):1756. doi: 10.3390/jcm10081756. J Clin Med. 2021. PMID: 33919494 Free PMC article.
Primary kidney malignant epithelioid angiomyolipoma: Two cases report and review of literature.
Zhan R, Li YQ, Chen CY, Hu HY, Zhang C. Zhan R, et al. Medicine (Baltimore). 2018 Aug;97(32):e11805. doi: 10.1097/MD.0000000000011805. Medicine (Baltimore). 2018. PMID: 30095646 Free PMC article.
Epithelioid Angiomyolipoma with Tumor Thrombus into Inferior Vena Cava Presurgically Treated with Combination Therapy of Pembrolizumab and Axitinib: A Case Report.
Kawasoe C, Miyamoto Y, Ito K, Murashima T, Nagai T, Takamori H, Kiwaki T, Kamimura T, Mukai S, Kamoto T. Kawasoe C, et al. Res Rep Urol. 2023 Oct 5;15:447-452. doi: 10.2147/RRU.S425887. eCollection 2023. Res Rep Urol. 2023. PMID: 37818232 Free PMC article.
A Case Report of Malignant Perivascular Epithelioid Cell Tumors of the Uterus and Literature Review.
Hu D, Miao M, Zhou H, Gu X, Wang X, Teichmann AT, Wang Q, Yang Y. Hu D, et al. Int J Womens Health. 2024 Apr 15;16:619-628. doi: 10.2147/IJWH.S453226. eCollection 2024. Int J Womens Health. 2024. PMID: 38645980 Free PMC article.
Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature review.
Flechter E, Zohar Y, Guralnik L, Passhak M, Sela GB. Flechter E, et al. Oncol Lett. 2016 Dec;12(6):4739-4743. doi: 10.3892/ol.2016.5231. Epub 2016 Oct 6. Oncol Lett. 2016. PMID: 28105182 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal